One-Year Survival Worse for Lung Retransplants Relative to Primary Lung Transplants.


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
04 2022
Historique:
received: 13 02 2021
revised: 18 03 2021
accepted: 27 03 2021
pubmed: 9 5 2021
medline: 5 4 2022
entrez: 8 5 2021
Statut: ppublish

Résumé

Outcomes after lung retransplantation (LRT) remain inferior compared with primary lung transplantation (PLT). This study examined the impact of center volume on 1-year survival after LRT. Using the United Network for Organ Sharing database, the study abstracted patients undergoing PLT and LRT between January 2006 and December 2017, excluding combined heart-lung transplants and multiple retransplants. One-year survival rates after PLT and LRT were compared using propensity score matching. In the LRT cohort, multivariable Cox models with and without time-dependent coefficients were fitted to examine association between transplant center volume and 1-year survival. Center volume was categorized on the basis of inspection of restricted cubic splines. A total of 20,675 recipients (PLT 19,853 [96.0%] vs LRT 822 [4.0%]) were included. One-year survival was lower for LRT recipients in the matched cohort (PLT 84.8% vs LRT 76.7%). There was steady improvement in 1-year survival after LRT (2006 to 2009 72.1% vs 2010 to 2013 76.6% vs 2014 to 2017 80.1%). Higher center volume was associated with better 1-year survival after LRT. This survival difference was noted in the initial 30 days after transplantation (intermediate vs low volume hazard ratio, 0.282 [95% confidence interval, 0.151 to 0.526]; high vs low volume hazard ratio, 0.406 [95% confidence interval, 0.224 to 0.737]), but it became insignificant after 30 days. Superior 1-year survival after LRT at higher-volume centers is predominantly the result of better 30-day outcomes. This finding suggests that LRT candidates may be referred to higher-volume centers for surgery.

Sections du résumé

BACKGROUND
Outcomes after lung retransplantation (LRT) remain inferior compared with primary lung transplantation (PLT). This study examined the impact of center volume on 1-year survival after LRT.
METHODS
Using the United Network for Organ Sharing database, the study abstracted patients undergoing PLT and LRT between January 2006 and December 2017, excluding combined heart-lung transplants and multiple retransplants. One-year survival rates after PLT and LRT were compared using propensity score matching. In the LRT cohort, multivariable Cox models with and without time-dependent coefficients were fitted to examine association between transplant center volume and 1-year survival. Center volume was categorized on the basis of inspection of restricted cubic splines.
RESULTS
A total of 20,675 recipients (PLT 19,853 [96.0%] vs LRT 822 [4.0%]) were included. One-year survival was lower for LRT recipients in the matched cohort (PLT 84.8% vs LRT 76.7%). There was steady improvement in 1-year survival after LRT (2006 to 2009 72.1% vs 2010 to 2013 76.6% vs 2014 to 2017 80.1%). Higher center volume was associated with better 1-year survival after LRT. This survival difference was noted in the initial 30 days after transplantation (intermediate vs low volume hazard ratio, 0.282 [95% confidence interval, 0.151 to 0.526]; high vs low volume hazard ratio, 0.406 [95% confidence interval, 0.224 to 0.737]), but it became insignificant after 30 days.
CONCLUSIONS
Superior 1-year survival after LRT at higher-volume centers is predominantly the result of better 30-day outcomes. This finding suggests that LRT candidates may be referred to higher-volume centers for surgery.

Identifiants

pubmed: 33964255
pii: S0003-4975(21)00825-0
doi: 10.1016/j.athoracsur.2021.03.112
pmc: PMC8568742
mid: NIHMS1703531
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1265-1273

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL146856
Pays : United States

Informations de copyright

Copyright © 2022 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Auteurs

Simran K Randhawa (SK)

Division of Cardiothoracic Surgery, Washington University School of Medicine in St Louis, St. Louis, Missouri. Electronic address: randhawa.sk18@gmail.com.

Zhizhou Yang (Z)

Division of Cardiothoracic Surgery, Washington University School of Medicine in St Louis, St. Louis, Missouri.

Deniz B Morkan (DB)

Division of Cardiothoracic Surgery, Washington University School of Medicine in St Louis, St. Louis, Missouri.

Yan Yan (Y)

Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine in St Louis, St. Louis, Missouri.

Su-Hsin Chang (SH)

Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine in St Louis, St. Louis, Missouri.

Ramsey R Hachem (RR)

Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri.

Chad A Witt (CA)

Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri.

Derek E Byers (DE)

Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri.

Hrishikesh S Kulkarni (HS)

Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri.

Rodrigo Vasquez Guillamet (RV)

Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri.

Benjamin D Kozower (BD)

Division of Cardiothoracic Surgery, Washington University School of Medicine in St Louis, St. Louis, Missouri.

Ruben G Nava (RG)

Division of Cardiothoracic Surgery, Washington University School of Medicine in St Louis, St. Louis, Missouri.

Bryan F Meyers (BF)

Division of Cardiothoracic Surgery, Washington University School of Medicine in St Louis, St. Louis, Missouri.

G Alexander Patterson (GA)

Division of Cardiothoracic Surgery, Washington University School of Medicine in St Louis, St. Louis, Missouri.

Daniel Kreisel (D)

Division of Cardiothoracic Surgery, Washington University School of Medicine in St Louis, St. Louis, Missouri.

Varun Puri (V)

Division of Cardiothoracic Surgery, Washington University School of Medicine in St Louis, St. Louis, Missouri.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH